New predictive tool may identify the risk of dementia within Parkinson’s

The Montreal Parkinson Risk of Dementia Scale (MoPaRDS), which comprises 8 simple clinical variables, is effective for predicting the risk for dementia in patients with Parkinson disease(PD), according to findings from a multicenter study published in JAMA Neurology.

Read More >>

Brown University receives $100M donation for brain disease research

One of the largest gifts in Brown University history, from Brown graduate Robert J. Carney and his wife, Nancy D. Carney, is intended to quicken the pace of neuroscience research in R.I., with the potential to develop new treatments and cures for such devastating conditions as Alzheimer’s disease and amyotrophic lateral sclerosis, or ALS.

Read More >>

Huntington’s disease dementia may hold clues for Alzheimer’s

The buildup of a specific chemical in the brain is an early sign of Huntington's dementia, and it could help with early detection of Alzheimer's disease and other dementias, says a new study.

Read More >>

Dementia rises to No. 1 killer in Britain

Advocacy groups say the government’s £132 million funding for Alzheimer’s research needs to be doubled for at least the next five years.

Read More >>

Diagnosing Lewy body disease at earlier stages

Research breakthrough: Scientists have identified symptoms that could lead to earlier diagnosis of Lewy body mild cognitive impairment.

Read More >>

Researchers study links between smell disorders and dementia

The study is the latest attempt to develop better olfactory tests that might be used to detect early stages of neurodegeneration.

Read More >>

UC San Diego, IBM Watson team up to study mild cognitive impairment

The study will use sensors, wearables and even gut bacteria to study how seniors with mild cognitive impairment think and remember.

Read More >>

Faulty sense of smell can be indicator of dementia

A Canadian study has connected memory loss and a confused nose. Could it lead to earlier detection of Alzheimer’s disease? 

Read More >>

Detecting muscle and bone loss

Researchers examine a new assessment test to determine a resident’s risk of age-related muscle and skeletal loss called sarcopenia.

Read More >>

Sleep apnea and cognitive decline

Sleep-disordered breathing may affect cognition, especially in those who carry the APOE-4 gene, thought to be a genetic risk factor for Alzheimer's.

Read More >>